Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000215668 | SCV000275476 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001086211 | SCV000290821 | likely benign | Familial cancer of breast | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000215668 | SCV000690822 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000842681 | SCV000984711 | likely benign | not provided | 2020-02-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485421 | SCV002797957 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2021-09-06 | criteria provided, single submitter | clinical testing |